ATE353138T1 - Verfahren zur stabilisierung und messung von troponinkomplexen - Google Patents

Verfahren zur stabilisierung und messung von troponinkomplexen

Info

Publication number
ATE353138T1
ATE353138T1 AT98964095T AT98964095T ATE353138T1 AT E353138 T1 ATE353138 T1 AT E353138T1 AT 98964095 T AT98964095 T AT 98964095T AT 98964095 T AT98964095 T AT 98964095T AT E353138 T1 ATE353138 T1 AT E353138T1
Authority
AT
Austria
Prior art keywords
stabilizing
troponin complexes
measuring
measuring troponin
complexes
Prior art date
Application number
AT98964095T
Other languages
English (en)
Inventor
Kenneth F Buechler
Paul H Mcpherson
Original Assignee
Biosite Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biosite Inc filed Critical Biosite Inc
Application granted granted Critical
Publication of ATE353138T1 publication Critical patent/ATE353138T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6887—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids from muscle, cartilage or connective tissue
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
    • G01N2333/47—Assays involving proteins of known structure or function as defined in the subgroups
    • G01N2333/4701—Details
    • G01N2333/4712—Muscle proteins, e.g. myosin, actin, protein
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2474/00—Immunochemical assays or immunoassays characterised by detection mode or means of detection
    • G01N2474/20—Immunohistochemistry assay
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/962—Prevention or removal of interfering materials or reactants or other treatment to enhance results, e.g. determining or preventing nonspecific binding
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/971—Capture of complex after antigen-antibody reaction
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/973—Simultaneous determination of more than one analyte
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/811—Test for named disease, body condition or organ function
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/819—Multifunctional antigen or antibody

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Cell Biology (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analyzing Non-Biological Materials By The Use Of Chemical Means (AREA)
  • Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
  • Sampling And Sample Adjustment (AREA)
AT98964095T 1997-12-19 1998-12-18 Verfahren zur stabilisierung und messung von troponinkomplexen ATE353138T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/993,750 US6156521A (en) 1997-12-19 1997-12-19 Methods for the recovery and measurement of troponin complexes

Publications (1)

Publication Number Publication Date
ATE353138T1 true ATE353138T1 (de) 2007-02-15

Family

ID=25539888

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98964095T ATE353138T1 (de) 1997-12-19 1998-12-18 Verfahren zur stabilisierung und messung von troponinkomplexen

Country Status (6)

Country Link
US (1) US6156521A (de)
EP (1) EP1042675B1 (de)
AT (1) ATE353138T1 (de)
AU (1) AU1929199A (de)
CA (1) CA2315186C (de)
DE (1) DE69837015T2 (de)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6627404B1 (en) * 1995-04-18 2003-09-30 Biosite, Inc. Methods for improving the recovery of troponin I and T in membranes, filters and vessels
US6991907B1 (en) * 1995-04-18 2006-01-31 Biosite, Inc. Methods for the assay of troponin I and T and complexes of troponin I and T and selection of antibodies for use in immunoassays
AU2001273348A1 (en) * 2000-07-10 2002-01-21 Diosynth Rtp, Inc. Purification of human troponin i
US20040121350A1 (en) * 2002-12-24 2004-06-24 Biosite Incorporated System and method for identifying a panel of indicators
US7524635B2 (en) * 2003-04-17 2009-04-28 Biosite Incorporated Methods and compositions for measuring natriuretic peptides and uses thereof
US7632647B2 (en) 2001-04-13 2009-12-15 Biosite Incorporated Use of B-type natriuretic peptide as a prognostic indicator in acute coronary syndromes
US20040203083A1 (en) * 2001-04-13 2004-10-14 Biosite, Inc. Use of thrombus precursor protein and monocyte chemoattractant protein as diagnostic and prognostic indicators in vascular diseases
US7713705B2 (en) * 2002-12-24 2010-05-11 Biosite, Inc. Markers for differential diagnosis and methods of use thereof
US20040253637A1 (en) * 2001-04-13 2004-12-16 Biosite Incorporated Markers for differential diagnosis and methods of use thereof
US20040126767A1 (en) * 2002-12-27 2004-07-01 Biosite Incorporated Method and system for disease detection using marker combinations
US20040176914A1 (en) * 2001-04-13 2004-09-09 Biosite Incorporated Methods and compositions for measuring biologically active natriuretic peptides and for improving their therapeutic potential
US20030199000A1 (en) * 2001-08-20 2003-10-23 Valkirs Gunars E. Diagnostic markers of stroke and cerebral injury and methods of use thereof
DE60233301D1 (de) 2001-05-04 2009-09-24 Biosite Inc Diagnostische marker für akute herzerkrankungen und verfahren des gebrauchs
US20040209307A1 (en) * 2001-08-20 2004-10-21 Biosite Incorporated Diagnostic markers of stroke and cerebral injury and methods of use thereof
US20040219509A1 (en) * 2001-08-20 2004-11-04 Biosite, Inc. Diagnostic markers of stroke and cerebral injury and methods of use thereof
US7608406B2 (en) * 2001-08-20 2009-10-27 Biosite, Inc. Diagnostic markers of stroke and cerebral injury and methods of use thereof
US6461828B1 (en) 2001-09-04 2002-10-08 Syn X Pharma Conjunctive analysis of biological marker expression for diagnosing organ failure
EP2386863A1 (de) * 2002-10-09 2011-11-16 DMI Biosciences, Inc. Diagnose und Uberwachung von Multiorganversagen
EP2005168A4 (de) * 2006-03-09 2009-05-20 Biosite Inc Verfahren und zusammensetzung zur diagnose von krankheiten der aorta
US20080118924A1 (en) * 2006-05-26 2008-05-22 Buechler Kenneth F Use of natriuretic peptides as diagnostic and prognostic indicators in vascular diseases
EP2092340B1 (de) * 2006-10-18 2014-07-09 Axela Inc. Messen mehrerer analyten über einen breiten konzentrationsbereich mittels optischer beugung
WO2008061149A2 (en) * 2006-11-14 2008-05-22 Biosite Incorporated Methods and compositions for diagnosis and prognosis of renal artery stenosis
EP2095107B1 (de) 2006-11-14 2014-07-02 Alere San Diego, Inc. Verfahren zur risikoabschätzung
EP2101178A1 (de) 2008-03-12 2009-09-16 BRAHMS Aktiengesellschaft Verwendung von Procalcitonin zur Prognose folgender akuter Koronarsyndromen
CN101790687A (zh) 2007-08-03 2010-07-28 B.R.A.H.M.S有限公司 降钙素原(pct)在患原发性非传染疾病的患者的风险分级和预后中的应用
EP2265950B1 (de) 2008-03-05 2019-01-23 Axela Inc. Nachweis von biomarkern und biomarker-komplexen
US20110306148A1 (en) 2010-06-14 2011-12-15 Siemens Healthcare Diagnostics Inc. Composition for use as an assay reagent
KR101975993B1 (ko) 2011-02-25 2019-05-07 가부시키가이샤 엘에스아이 메디엔스 심근 트로포닌의 측정법
US10670611B2 (en) 2014-09-26 2020-06-02 Somalogic, Inc. Cardiovascular risk event prediction and uses thereof
CN107870238B (zh) * 2016-09-28 2023-12-26 上海仪电分析仪器有限公司 一种定量测量人血清中肌钙蛋白I（cTnI）的方法
CN113125745B (zh) * 2019-12-31 2022-10-28 瑞博奥(广州)生物科技股份有限公司 一种心脏功能检测试剂盒

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4933275A (en) * 1985-10-24 1990-06-12 The General Hospital Corporation Method for the detection of a polypeptide subunit in the presence of a quaternary protein containing the subunit
US5051356A (en) * 1988-06-13 1991-09-24 Eastman Kodak Company Specific binding composition comprising a low pI protein or carbohydrate and a diagnostic test kit and method of use
DE3922873A1 (de) * 1989-04-25 1990-10-31 Boehringer Mannheim Gmbh Spezifische antikoerper gegen troponin t, ihre herstellung und verwendung in einem reagenz zur bestimmung von hermuskelnekrosen
EP0473787A1 (de) * 1990-02-28 1992-03-11 Takeda Chemical Industries, Ltd. Verbesserter Immunoanalyse
US5143852A (en) * 1990-09-14 1992-09-01 Biosite Diagnostics, Inc. Antibodies to ligand analogues and their utility in ligand-receptor assays
CA2027434C (en) * 1990-10-12 1999-01-05 George Jackowski Diagnostic kit for diagnosing and distinguishing chest pain in early onset thereof
US5246001A (en) * 1992-03-31 1993-09-21 Duke University Method of assessing reperfusion after thrombolytic therapy
DE4243648A1 (de) * 1992-12-23 1994-07-07 Boehringer Mannheim Gmbh Verfahren zur Bestimmung von Herzmuskelnekrosen mittels Antikörper gegen das N-terminale Troponin I-Peptid
FR2701954B1 (fr) * 1993-02-23 1995-07-07 Pasteur Sanofi Diagnostics Composition stabilisée de troponine pour immunoessais et procédé de stabilisation de troponine pour immunoessais.
WO1994027156A1 (en) * 1993-05-17 1994-11-24 Fortron Bioscience, Inc. Assay for cardiac troponin i
EP0672354B1 (de) * 1994-03-18 2000-07-12 Ajinomoto Co., Inc. Proteinhaltiges Mittel zur Verbesserung der Geschmacksqualität von Lebensmitteln
US6165981A (en) * 1995-03-07 2000-12-26 Dade Behring Inc. Stabilizing solutions for proteins and peptides
US6627404B1 (en) * 1995-04-18 2003-09-30 Biosite, Inc. Methods for improving the recovery of troponin I and T in membranes, filters and vessels
US5795725A (en) * 1995-04-18 1998-08-18 Biosite Diagnostics Incorporated Methods for the assay of troponin I and T and selection of antibodies for use in immunoassays
WO1998056900A1 (en) * 1997-06-13 1998-12-17 Medical Analysis Systems Inc. (Mas) Stabilized compositions of cardiac markers

Also Published As

Publication number Publication date
DE69837015D1 (de) 2007-03-22
CA2315186A1 (en) 1999-07-01
CA2315186C (en) 2009-05-05
DE69837015T2 (de) 2007-06-06
US6156521A (en) 2000-12-05
AU1929199A (en) 1999-07-12
EP1042675A1 (de) 2000-10-11
EP1042675B1 (de) 2007-01-31

Similar Documents

Publication Publication Date Title
ATE353138T1 (de) Verfahren zur stabilisierung und messung von troponinkomplexen
DE3776302D1 (de) Verfahren zur feststellung von gasen unter anwendung von chemisorption und physisorption.
DE60014348D1 (de) Messung und verwendung von molekularen wechselwirkungen
DE58908694D1 (de) Oligonucleotidbank und verfahren zur dna-sequenzierung.
DE69022786D1 (de) Verfahren zur Bestimmung der Konzentration von Glucose.
DE3851286T2 (de) Verfahren und Vorrichtung zur Rekonstruktion von fehlenden Farbabtastwerten.
DE3676974D1 (de) Verfahren zur quantitativen messung von kohlenwasserstoffen.
DE69718094D1 (de) Verfahren und Kit zur Messung von Hämoglobin A1c
DE69022425T2 (de) Verfahren zur Bestimmung der funktionellen Wirkung von freiem Protein S oder Protein C in einer Plasmaprobe.
DE69936553D1 (de) Verfahren zur Konzentrationsmessung von NOx
DE3682547D1 (de) Verfahren und vorrichtung zur rekonstruktion von fehlenden farbabtastwerten.
DE3586006D1 (de) Verfahren und zusammensetzungen zur expression von bti-endo-toxin.
DE3486081T2 (de) Verfahren und testzusammensetzung zur bestimmung von wasserstoffperoxid.
DE3863285D1 (de) Verfahren und reagenz zur bestimmung von persaeuren.
DE3582758D1 (de) Verfahren und anordnung zur entdeckung von schmuggelsubstanz.
DE69112090T2 (de) Verfahren und Vorrichtung zur Messung von Musterdimensionen.
DE3682902D1 (de) Verfahren zur steigerung des grades von oelextraktion.
DE68912187D1 (de) Zusammensetzung für und Verfahren zur Leimung.
DE59812368D1 (de) Verfahren zur verbrennungslosen messung des brennwertes von brenngas
DE3580771D1 (de) Standardmaterial zur messung von immunologischen komplexen und verfahren zur messung von immunologischen komplexen.
DE69909419D1 (de) Indium-enthaltende Zusammensetzung zur Messung von Proteinspuren
DE69029461D1 (de) Verfahren zur messung und kontrolle von texturen.
DE3678621D1 (de) Verfahren und testzusammensetzung zur bestimmung von wasserstoffperoxyd.
ATE64470T1 (de) Verfahren und zusammensetzungen zur bestimmung von heparin.
DE3581530D1 (de) Verfahren und vorrichtung zur wirbelstrom feststellung von fehlern.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties